1,078
Views
12
CrossRef citations to date
0
Altmetric
Review

Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia

, , , , &
Article: e1132977 | Received 21 Oct 2015, Accepted 12 Dec 2015, Published online: 11 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Audrey Mohr, Marie Cumin, Cristina Bagacean, Pierre Pochard, Christelle Le Dantec, Sophie Hillion, Yves Renaudineau, Christian Berthou, Adrian Tempescul, Hussam Saad, Jacques-Olivier Pers, Anne Bordron & Christophe Jamin. (2019) The regulatory capacity of B cells directs the aggressiveness of CLL. OncoImmunology 8:3.
Read now

Articles from other publishers (11)

Cristian Iperi, Anne Bordron, Maryvonne Dueymes, Jacques-Olivier Pers & Christophe Jamin. (2021) Metabolic Program of Regulatory B Lymphocytes and Influence in the Control of Malignant and Autoimmune Situations. Frontiers in Immunology 12.
Crossref
Naseba Naseraldeen, Regina Michelis, Masad Barhoum, Judith Chezar, Tamar Tadmor, Ariel Aviv, Lev Shvidel, Adi Litmanovich, Mona Shehadeh, Galia Stemer, Ety Shaoul & Andrei Braester. (2021) The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia. Frontiers in Immunology 11.
Crossref
Alak MannaTimothy KellettSonikpreet Aulakh, Laura J. Lewis-TuffinNavnita DuttaKeith KnutsonEduardo ChiniJavier Pinilla-IbarzNicole LamannaRami ManochakianFabio Malavasi, Taimur SherAsher A. Chanan-Khan, Sikander AilawadhiAneel Paulus. (2020) Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses. Blood Advances 4:10, pages 2143-2157.
Crossref
Min Liu, Qian Sun, Jian Wang, Feng Wei, Lili Yang & Xiubao Ren. (2018) A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity. International Journal of Cancer 144:12, pages 2909-2917.
Crossref
Xiaoqin Jia, Hao Liu, Chong Xu, Sen Han, Yating Shen, Xin Miao, Xiangyu Hu, Zhijie Lin, Li Qian, Zhengbing Wang & Weijuan Gong. (2019) MiR-15a/16-1 deficiency induces IL-10-producing CD19 + TIM-1 + cells in tumor microenvironment . Journal of Cellular and Molecular Medicine 23:2, pages 1343-1353.
Crossref
Yiqing Cai, Lili Feng & Xin Wang. (2018) Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia. Critical Reviews in Oncology/Hematology 126, pages 24-31.
Crossref
Michael Bonelli & Clemens Scheinecker. (2018) How does abatacept really work in rheumatoid arthritis?. Current Opinion in Rheumatology 30:3, pages 295-300.
Crossref
Kahina Amrouche & Christophe Jamin. (2017) Influence of drug molecules on regulatory B cells. Clinical Immunology 184, pages 1-10.
Crossref
Erika Jensen-Jarolim, Michelle C. Turner & Sophia N. Karagiannis. (2017) AllergoOncology: IgE- and IgG 4 -mediated immune mechanisms linking allergy with cancer and their translational implications. Journal of Allergy and Clinical Immunology 140:4, pages 982-984.
Crossref
Pierre Gazeau, Guillermo Carvajal Alegria, Valérie Devauchelle-Pensec, Christophe Jamin, Julie Lemerle, Boutahar Bendaoud, Wesley H Brooks, Alain Saraux, Divi Cornec & Yves Renaudineau. (2017) Memory B Cells and Response to Abatacept in Rheumatoid Arthritis. Clinical Reviews in Allergy & Immunology 53:2, pages 166-176.
Crossref
Barry D. Hock, Sean A. MacPherson & Judith L. McKenzie. (2017) Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells. PLOS ONE 12:3, pages e0172858.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.